STAGWELL INC Stock Price, News & Analysis

U.S. News & World Report, in collaboration with The Harris Poll, has released a comprehensive survey revealing a widespread leadership crisis across American institutions. The poll of 1,500 adults shows significant distrust in leaders across public service, business, education, and healthcare sectors.

Key findings include 77% of respondents not seeing any admirable public leaders, 82% believing business leaders are out of touch with public values, and 85% perceiving government officials as prioritizing self-interest. The survey will inform U.S. News' upcoming Best Leaders in America program, which will recognize 25 exceptional individuals making meaningful contributions across various sectors.

Stagwell (NASDAQ: STGW), a challenger network focused on marketing transformation, has announced its participation in three key investor conferences in August 2025. The company's schedule includes the Morgan Stanley Media & Communications Corporate Access Day on August 12 with CFO Ryan Greene conducting in-person meetings, the Rosenblatt 5th Annual Tech Summit: The Age of AI on August 19 with virtual meetings, and the Seaport Research Partners Annual Summer Investor Conference on August 20 with virtual one-on-one meetings.

A comprehensive survey conducted by The Harris Poll, a Stagwell (STGW) company, in partnership with the American Gastroenterological Association (AGA), reveals significant ongoing challenges faced by IBS patients. The study, comparing data from 2015 to 2024, surveyed 2,013 IBS patients and 600 healthcare providers.

Key findings show that IBS symptoms disrupt patients' productivity for nearly 11 days per month at work/school and 8 days in personal activities. Work/school absences have increased from 2.1 days in 2015 to 3.6 days in 2024. While fewer patients report extremely bothersome symptoms (43% vs 62% in 2015), 76% still find symptom management difficult.

The survey highlights a treatment gap, with healthcare providers primarily recommending over-the-counter options and lifestyle changes despite prescription medications being reported as most helpful by patients who have tried them.

Stagwell Inc. (NASDAQ: STGW) reported strong Q2 2025 financial results, with net revenue growth of 8% reaching $598 million and 10% growth excluding Advocacy business. The company achieved Adjusted EBITDA of $93 million, up 8% year-over-year, with ex-Advocacy EBITDA growing 23% to $80 million.

Key highlights include $117 million in net new business for Q2, significant improvement in cash flow from operations with a $122 million increase over the prior year, and progress on cost savings initiatives with $20 million in annualized savings achieved. The company reiterated its 2025 guidance, projecting approximately 8% total net revenue growth and Adjusted EBITDA between $410-460 million.

A groundbreaking study by the Schultz Family Foundation and HarrisX reveals a critical crisis in America's school-to-work transition system, affecting approximately 30 million young adults. The research, based on 5,771 interviews, exposes significant misalignment between educators, employers, and parents.

Key findings show that 43% of young adults consider the education system broken, while 46% feel unprepared for future jobs due to AI impacts. Notably, 77% of employers require experience for entry-level positions, yet most don't offer internship programs. The study also revealed that 70% of young adults rely on social media for career guidance, while only 16% of parents encourage this approach.

The research highlights a concerning gender gap, with only 50% of young women feeling prepared for future jobs compared to 60% of men. Mental health emerged as a critical factor, with 51% of young women reporting challenges versus 36% of men.

Stagwell (NASDAQ: STGW) released the July Harvard CAPS / Harris poll results showing President Trump's approval rating at 47% (+1 pt from June 2025). The poll revealed split opinions on the "Big Beautiful Bill" with 47% voter support, though most individual policies within the bill have majority backing.

Key findings include: 45% of voters citing inflation as their top concern, 69% believing Biden's open border was deliberate policy, and 80% supporting U.S. actions to prevent Iran's nuclear capabilities. The poll surveyed 2,044 registered voters from July 6-8, 2025, covering economic sentiment, immigration policy, Middle East conflicts, and Ukraine-Russia relations.

Stagwell (NASDAQ: STGW) released the July Harvard CAPS / Harris poll results, showing President Trump's approval rating at 47% (+1 point from June 2025). The comprehensive poll revealed that 44% of voters support the "Big Beautiful Bill," with 17 out of 21 policy proposals receiving majority support. Key findings include 45% of voters citing inflation and affordability as their top concern, up 6 points from June.

The poll highlighted that 62% of voters hold Trump responsible for the current economic state, while 56% believe he's losing the battle against inflation. On foreign policy, 58% support the administration's strike on Iran's nuclear sites, and 80% of voters support preventing Iran from obtaining nuclear weapons. Immigration remains contentious, with 60% supporting efforts to close the southern border.

Stagwell (NASDAQ: STGW) has announced the launch of its Stagwell Media Platform (SMP), a centralized global team focused on media, technology, and data expertise. The platform aims to optimize trading and investment solutions across Stagwell's global network.

Matt Adams, current Global COO of Assembly Global, will serve as Global CEO of SMP, while Marissa Jimenez joins as Global Chief Trading and Solutions Officer, effective July 14, 2025. Jimenez brings 20 years of industry experience from her previous role as EVP, Commercial at Dentsu US.

The SMP will leverage Stagwell's scale, technology, and partnerships to enhance efficiency and outcomes for clients, offering solutions across creative, media, and digital transformation services.

Nature Made (NYSE:STGW) has achieved significant recognition in U.S. News & World Report's 2025 Best OTC Medicine & Health Products survey, securing eight #1 rankings across various vitamin and supplement categories. The survey, conducted in partnership with The Harris Poll, gathered insights from 357 pharmacists and 134 dermatologists across 133 categories.

The brand topped rankings in key categories including Best Vitamin Brands, Anti-Stress Supplements, Ashwagandha Supplements, Potassium Supplements, Turmeric Supplements, Vitamin B12 Supplements, Prenatal Vitamins, and Vitamin D Supplements. This recognition reinforces Nature Made's position as the #1 Pharmacist Recommended vitamin and supplement brand with over 50 years of expertise.